SUCLG1 and cholangiocarcinoma: Here, we based our ex vivo and in silico study on a meta-analysis of 127 transcriptomic datasets from mice, rats, and humans, identifying a transcriptomic signature of aging across species and tissues [21], and identified SUCLG1 as a commonly downregulated protein in both HCC and CC tissue, which also associates to lower patient survival.